Returning OTC products boost J&J in US

21 October 2013 - Deborah Wilkes

Archived

Johnson & Johnson's OTC sales in the US increased by 17.9% to US$310 million in the third quarter of 2013, as the company continued to return its recalled products to shelves.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: